Designing an Advanced Cancer Therapeutic Protein (GABPA Binding Inhibitor) Using an Artificial Intelligence-based DNA Binding Protein Design system.
- đ¤ Speaker: Haseem Deen Mohamed Sarif Mohamed Iqbal, University of Cambridge đ Website
- đ Date & Time: Wednesday 18 May 2022, 15:00 - 15:30
- đ Venue: Wolfson Lecture Theatre, Dept of Chemistry and Zoom
Abstract
First Year PhD Report: Transcription factors (TF) are DNA binding proteins that regulate the gene expression mechanism. Different combinations of TF that are bound at the DNA promotor (transcription initiation region in a gene) determine whether a gene is switched on or off. Many complex diseases and organ development are related to the transcription factor machinery. Our ambitious goal is to design novel functional protein folds to interrupt gene switch mechanisms. Thus, we could develop advanced treatments for different kinds of diseases, including cancer, and in tissue regenerative applications.
We are developing an artificial intelligence-based protein designing system. In the first step, we have developed a method to translate a 3D geometry of a protein structure into a 1D structural language sequence that represents the 3D protein structure. The sequence could be used as input to a special type of RNN (Recurrent Neural Network) to learn how to build a novel fold using a fragment library guided own variational protein set. To test the system, we have designed a highly specific cancer therapeutic protein structure.
The system development is ongoing. We will optimise the designed protein using a self-learning RNN .
Series This talk is part of the Theory - Chemistry Research Interest Group series.
Included in Lists
- All Talks (aka the CURE list)
- Department of Chemistry
- Featured lists
- Lennard-Jones Centre external
- School of Physical Sciences
- Wolfson Lecture Theatre, Dept of Chemistry and Zoom
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)



Wednesday 18 May 2022, 15:00-15:30